Stock Acquisition Rights for Directors and Executive Officers
First written in FY2017-Q2. 6 of 8 entries say "Advanced", first in FY2018-Q2. Latest entry: 2026-08-06.
15 other companies' latest entry also says "Advanced".
- FY2021ReframedAnnual report
「The company changed its stock-based compensation system from stock options granted as non-monetary compensation within an annual limit of ¥100 million at a specified time each year to restricted shares.」
For stock-based compensation for directors and executive officers, the company changed the system from the former stock-based compensation stock options to restricted shares. - FY2020AdvancedAnnual report
「Resolution date 31 July 2020 Eligible persons and number Company directors, excluding outside directors: 5 Company executive officers who do not concurrently serve as company directors: 20 Number of stock acquisition rights (Note 1) 9,061 Class, details and number of shares underlying the stock acquisition rights (Note 2) Common shares: 90,610 shares」
The company resolved to newly allot 9,061 stock acquisition rights covering 90,610 shares to directors and executive officers. - FY2019AdvancedAnnual report
「Resolution date: 26 June 2019; eligible persons and number: 5 company directors, excluding outside directors; 21 company executive officers who do not concurrently serve as company directors; number of stock acquisition rights (Note 1): 5,767; class, details and number of shares underlying the stock acquisition rights (Note 2): common shares, 57,670 shares.」
The company resolved to newly allot 5,767 stock acquisition rights covering 57,670 shares to directors and executive officers. - FY2018AdvancedAnnual report
「Number of stock acquisition rights (Note 1): 5,638; class, details and number of shares underlying the stock acquisition rights (Note 2): common shares, 56,380 shares; exercise period: from 1 August 2018 to 31 July 2048.」
The company described a plan to allot new stock options in the form of stock-based compensation to 5 directors and 22 executive officers, based on the resolution of 27 June 2018. - FY2018-Q2AdvancedAnnual report
「Number of stock acquisition rights (rights): 7,321; number of shares underlying the stock acquisition rights (shares): 73,210; exercise period: from 1 August 2017 to 31 July 2047.」
Based on the resolution of 28 June 2017, the company issued 7,321 stock acquisition rights covering 73,210 shares to directors and executive officers. - FY2017-Q2First statedAnnual report
「The stock acquisition rights issued during the second quarter accounting period were as follows: number of stock acquisition rights, 9,630; number of shares underlying the stock acquisition rights, 96,300; exercise price, ¥1 per share; exercise period, from 30 July 2016 to 29 July 2046.」
The company issued 9,630 stock acquisition rights covering 96,300 shares to directors and executive officers. The exercise price is ¥1 per share, and the rights may be exercised from 30 July 2016 to 29 July 2046, generally in a lump sum within 10 days after the holder ceases to hold both positions.